NCT00525278View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
RhinitisAllergicSeasonal
Interventions
DRUG

Levocetirizine dihydrochloride

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00525278 - To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter